Azafaros
Leiden, NL · 11 known investors
Find your way into Azafaros
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions. The company's lead program, nizubaglustat, is currently in Phase 3 trials.
Founders & leadership
HA
Hans AertsProfessor
HO
Hermen OverkleeftProfessor
SV
Stan van BoeckelProfessor
Investors · 11
BioMedPartners✓ verifiedBasel · $648K – $6.5M
Forbion✓ verifiedNaarden
Jeito Capital✓ verifiedParis
BioGeneration Ventures✓ verifiedNaarden
Pictet Group✓ verifiedGeneva
Seroba Life SciencesDublin · $540K – $7.6M
Also in the syndicate · 5
BioGeneration Ventures (BGV)Forbion GrowthleadForbion VenturesSchroders CapitalSeroba
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMay 2025 · 5 sources
Forbion Growth (lead), Jeito Capital (lead), BioGeneration Ventures (BGV), Forbion Ventures, Pictet Group, Schroders Capital, Seroba
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlapCompanies competing with Azafaros for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Azafaros do?
- Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions. The company's lead program, nizubaglustat, is currently in Phase 3 trials.
- Who founded Azafaros?
- Azafaros was founded by Hans Aerts, Hermen Overkleeft, Stan van Boeckel.
- Who are Azafaros's investors?
- Azafaros's investors include BioMedPartners, Forbion, Jeito Capital, BioGeneration Ventures, Pictet Group, Seroba Life Sciences.
- Where is Azafaros headquartered?
- Azafaros is headquartered in Leiden, NL.